UNSPSC 85816230: Introduction of recombinant human-activated protein c into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of recombinant human-activated protein c into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E03016

UNSPSC 85816230 Introduction of recombinant human-activated protein C into peripheral vein, open approach is a Commodity code that shows little relevant recent activity under its nominal clinical procedure scope. The recent opportunities tagged to this code reflect a significant mismatch: they encompass virtual urgent care services, medical services procurement, Program of All Inclusive Care for the Elderly (PACE) operations, rural value-based care facilitation, cancer registry services, handheld retinal screening devices, jail EMT staffing, employee health clinic administration, occupational health and wellness services, histology lab services, travel nurse staffing, independent medical evaluations, medical director positions, health commons services, psychological evaluations, and opioid use disorder treatment — a broad spectrum of healthcare delivery, administration, and support services entirely unrelated to the administration of a specific therapeutic pharmaceutical into peripheral veins via open approach.

State and local issuing bodies across California, Georgia, Nevada, Colorado, Florida, Arizona, Texas, Illinois, New Jersey, New York, and multiple other jurisdictions are actively soliciting these healthcare services through RFPs, RFQs, and IFBs, but none reflect procurement of recombinant activated protein C administration. The code appears to have been misapplied by upstream taxonomic assignments rather than representing genuine market activity for this specific procedure at state and local level. Practitioners should verify the actual commodity or service code when evaluating state and local healthcare opportunities, as the abstract code name and current procurement reality diverge substantially.